Filing Flows › Comparisons › BIAF vs ONMD
bioAffinity Technologies vs OneMedNet: BIAF and ONMD compared
bioAffinity Technologies is the larger company: $1.1M of revenue in its latest quarter (Q3 2026) against $292K for OneMedNet (Q2 2026). OneMedNet is growing faster (+88% against -26% a year earlier). bioAffinity Technologies is more profitable, with an operating margin of -328.0% against -774.3%.
Where the money goes: BIAF and ONMD
bioAffinity Technologies (BIAF) · Q3 2026
bioAffinity Technologies, Q3 2026: revenue $1.1M (-26% year over year), operating margin -328.0%, net loss $5.3M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
OneMedNet (ONMD) · Q2 2026
OneMedNet, Q2 2026: revenue $292K (+88% year over year), operating margin -774.3%, net loss $2.2M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
| bioAffinity Technologies (BIAF) | OneMedNet (ONMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $1.1M | $292K |
| Revenue growth, Y/Y | -26% | +88% |
| Operating margin | -328.0% | -774.3% |
| Net earnings | −$5.3M | −$2.2M |
| Net margin | -493.1% | -743.8% |
| Operating cash flow | −$3.9M | −$1.9M |
Where the revenue comes from
bioAffinity Technologies
- Health Care, Patient Service: $863K (81%)
- Histology Service Fees: $190K (18%)
- Medical Director Fees: $17K (2%)
Questions
Which is bigger, bioAffinity Technologies or OneMedNet?
bioAffinity Technologies is the larger company: $1.1M of revenue in its latest quarter (Q3 2026) against $292K for OneMedNet (Q2 2026).
Is bioAffinity Technologies or OneMedNet growing faster?
OneMedNet is growing faster (+88% against -26% a year earlier).
Which is more profitable, bioAffinity Technologies or OneMedNet?
bioAffinity Technologies is more profitable, with an operating margin of -328.0% against -774.3%.
More: bioAffinity Technologies earnings · how bioAffinity Technologies makes money · OneMedNet earnings · how OneMedNet makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.